Frontiers | Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
Handling different accrual recalculation scenarios on Leave of Absence in Employee Central | SAP Blogs
Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection - European Urology
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis - The Lancet Oncology
Nikhil Kamath: India's youngest billionaire on his country's future
FGFR2: Breast Cancer Suneel Kamath SABCS 2022 ReFocus Trial